NHS National Framework Agreement for the supply of products for the treatment of Bleeding Disorders, including Haemophilia B
Estimated value
—
Awarded value
—
Suppliers
25
Lots
18
Published
04 Jul 2022
Description
National Framework Agreement for the supply of products for the treatment of Bleeding Disorders including Haemophilia B. The framework will commence on 1 July 2022 for a period of 24 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 moths. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the invitation to offer documents for a list of the purchasing points.
Scope
- Reference
- CM/PHS/19/5576
- Commercial tool
- Standalone contract
- Contract dates
- 30 Jun 2022 to 30 Jun 2024
- Main category
- goods
- CPV classifications
- 33141530
- Contract locations
- UK
Award criteria
Criteria the buyer will use to evaluate bids.
| Name | Description | Type | Weighting |
|---|---|---|---|
| Security of Supply | 15% | quality | — |
| Ease of Use | 10% | quality | — |
| — | 75% | price | — |
| Ease of Use 10% | 10% | quality | — |
Submission & procedure
- Procedure
- Open procedure
Award details· 25 awards
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
—
Award date
—
Contract start
—
Contract end
—
Lots · 18 total
Divisions of the contract. Each lot can be awarded separately.
| Lot | Title | Est. value | Status |
|---|---|---|---|
| 18 | Lot 18 - Fresh Frozen Plasma | £1 | cancelled |
| 16 | Lot 16 - Prothrombin Complex dried | £1 | cancelled |
| 15 | Lot 15 - Fibrinogen Concentrate | £1 | cancelled |
| 14 | Lot 14 - Von willebrands factor - Recombinant | £1 | cancelled |
| 17 | Lot 17 - Protein C Concentrate | £1 | cancelled |